ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,696, issued on April 15, was assigned to Trevi Therapeutics Inc. (New Haven, Conn.).
"Methods of administering nalbuphine" was invented by Thomas Sciascia (Belmont, Mass.) and Shashank Rohatagi (New Haven, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating nalbuphine-treatable disorders in a hepatically impaired patient."
The patent was filed on May 9, 2022, under Application No. 17/739,848.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12...